NCT07298785 Peer-led Dynamic Choice HIV Prevention for Women: The Peer-led DCP Pilot Study
| NCT ID | NCT07298785 |
| Status | Recruiting |
| Phase | — |
| Sponsor | University of California, San Francisco |
| Condition | HIV/AIDS |
| Study Type | INTERVENTIONAL |
| Enrollment | 60 participants |
| Start Date | 2026-01-27 |
| Primary Completion | 2027-06-30 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.
This trial targets 60 participants in total. It began in 2026-01-27 with a primary completion date of 2027-06-30.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
This study will refine and pilot test the Peer-led Dynamic Choice HIV Prevention (DCP) intervention in a single-arm pilot trial. The study will test the hypothesis that the Peer-led Dynamic Choice HIV Prevention intervention will be feasible and increase biomedical HIV prevention coverage in the 6 months after receipt of the Peer-led DCP intervention compared to the standard of care in the 6 months prior to intervention implementation.
Eligibility Criteria
Inclusion Criteria: 1. Age \>=18 years or mature or mature minor \>=15 years; 2. Female sex at birth; 3. HIV negative by country-standard testing algorithm 4. Elevated risk of HIV exposure, defined as at least 1 of the following: a) eligible for PrEP based on Uganda Ministry of Health Guidelines; b) exchange of sex for goods or money in last 6 months; or c) work in bar or guesthouse Exclusion Criteria: * Contraindication to country-recommended PrEP regimen per national guidelines * Participation in another HIV prevention study
Contact & Investigator
Catherine Koss, MD
PRINCIPAL INVESTIGATOR
University of California, San Francisco
Frequently Asked Questions
Who can join the NCT07298785 clinical trial?
This trial is open to female participants only, aged 15 Years or older, studying HIV/AIDS. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT07298785 currently recruiting?
Yes, NCT07298785 is actively recruiting participants. Contact the research team at catherine.koss@ucsf.edu for enrollment information.
Where is the NCT07298785 trial being conducted?
This trial is being conducted at Kampala, Uganda.
Who is sponsoring the NCT07298785 clinical trial?
NCT07298785 is sponsored by University of California, San Francisco. The principal investigator is Catherine Koss, MD at University of California, San Francisco. The trial plans to enroll 60 participants.
Related Trials
Related Intelligence Guides
In-depth guides covering this condition's trials, eligibility, and what to expect.